373 related articles for article (PubMed ID: 18583546)
21. Prevotella intermedia induces prostaglandin E2 via multiple signaling pathways.
Guan SM; Fu SM; He JJ; Zhang M
J Dent Res; 2011 Jan; 90(1):121-7. PubMed ID: 21057037
[TBL] [Abstract][Full Text] [Related]
22. Prostaglandin E2 is an enhancer of interleukin-1beta-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibroblasts.
Kojima F; Naraba H; Sasaki Y; Beppu M; Aoki H; Kawai S
Arthritis Rheum; 2003 Oct; 48(10):2819-28. PubMed ID: 14558087
[TBL] [Abstract][Full Text] [Related]
23. Prostaglandin E2 augments IL-10 signaling and function.
Cheon H; Rho YH; Choi SJ; Lee YH; Song GG; Sohn J; Won NH; Ji JD
J Immunol; 2006 Jul; 177(2):1092-100. PubMed ID: 16818766
[TBL] [Abstract][Full Text] [Related]
24. Prostaglandin E2 stimulates human lung carcinoma cell growth through induction of integrin-linked kinase: the involvement of EP4 and Sp1.
Zheng Y; Ritzenthaler JD; Sun X; Roman J; Han S
Cancer Res; 2009 Feb; 69(3):896-904. PubMed ID: 19176380
[TBL] [Abstract][Full Text] [Related]
25. Silymarin suppresses the PGE2 -induced cell migration through inhibition of EP2 activation; G protein-dependent PKA-CREB and G protein-independent Src-STAT3 signal pathways.
Woo SM; Min KJ; Chae IG; Chun KS; Kwon TK
Mol Carcinog; 2015 Mar; 54(3):216-28. PubMed ID: 24127286
[TBL] [Abstract][Full Text] [Related]
26. Prostaglandin E(2) induces caspase-dependent apoptosis in rat cortical cells.
Takadera T; Yumoto H; Tozuka Y; Ohyashiki T
Neurosci Lett; 2002 Jan; 317(2):61-4. PubMed ID: 11755240
[TBL] [Abstract][Full Text] [Related]
27. Suppression of prostaglandin E2 receptor subtype EP2 by PPARgamma ligands inhibits human lung carcinoma cell growth.
Han S; Roman J
Biochem Biophys Res Commun; 2004 Feb; 314(4):1093-9. PubMed ID: 14751245
[TBL] [Abstract][Full Text] [Related]
28. 3-OH flavone inhibition of epidermal growth factor-induced proliferaton through blocking prostaglandin E2 production.
Shen SC; Ko CH; Hsu KC; Chen YC
Int J Cancer; 2004 Feb; 108(4):502-10. PubMed ID: 14696113
[TBL] [Abstract][Full Text] [Related]
29. Leptin stimulates proliferation and inhibits apoptosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation.
Ogunwobi O; Mutungi G; Beales IL
Endocrinology; 2006 Sep; 147(9):4505-16. PubMed ID: 16740977
[TBL] [Abstract][Full Text] [Related]
30. Prostaglandin E2 downregulates TNF-alpha-induced production of matrix metalloproteinase-1 in HCS-2/8 chondrocytes by inhibiting Raf-1/MEK/ERK cascade through EP4 prostanoid receptor activation.
Fushimi K; Nakashima S; You F; Takigawa M; Shimizu K
J Cell Biochem; 2007 Feb; 100(3):783-93. PubMed ID: 17031853
[TBL] [Abstract][Full Text] [Related]
31. Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP.
Aronoff DM; Canetti C; Peters-Golden M
J Immunol; 2004 Jul; 173(1):559-65. PubMed ID: 15210817
[TBL] [Abstract][Full Text] [Related]
32. Stimulation of prostaglandin EP2 receptors prevents NMDA-induced excitotoxicity.
Ahmad AS; Zhuang H; Echeverria V; Doré S
J Neurotrauma; 2006 Dec; 23(12):1895-903. PubMed ID: 17184197
[TBL] [Abstract][Full Text] [Related]
33. Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM-CSF.
Clarke DL; Belvisi MG; Catley MC; Yacoub MH; Newton R; Giembycz MA
Br J Pharmacol; 2004 Apr; 141(7):1141-50. PubMed ID: 15023863
[TBL] [Abstract][Full Text] [Related]
34. Prostaglandin E2-stimulated prostanoid EP4 receptors induce prolonged de novo prostaglandin E2 synthesis through biphasic phosphorylation of extracellular signal-regulated kinases mediated by activation of protein kinase A in HCA-7 human colon cancer cells.
Fujino H; Seira N; Kurata N; Araki Y; Nakamura H; Regan JW; Murayama T
Eur J Pharmacol; 2015 Dec; 768():149-59. PubMed ID: 26518053
[TBL] [Abstract][Full Text] [Related]
35. Tissue-specific mechanisms for CCN2/CTGF persistence in fibrotic gingiva: interactions between cAMP and MAPK signaling pathways, and prostaglandin E2-EP3 receptor mediated activation of the c-JUN N-terminal kinase.
Black SA; Palamakumbura AH; Stan M; Trackman PC
J Biol Chem; 2007 May; 282(21):15416-29. PubMed ID: 17428796
[TBL] [Abstract][Full Text] [Related]
36. Peptidoglycan-induced IL-6 production in RAW 264.7 macrophages is mediated by cyclooxygenase-2, PGE2/PGE4 receptors, protein kinase A, I kappa B kinase, and NF-kappa B.
Chen BC; Liao CC; Hsu MJ; Liao YT; Lin CC; Sheu JR; Lin CH
J Immunol; 2006 Jul; 177(1):681-93. PubMed ID: 16785567
[TBL] [Abstract][Full Text] [Related]
37. Prostaglandin E
Lian S; Xia Y; Ung TT; Khoi PN; Yoon HJ; Lee SG; Kim KK; Jung YD
Mol Carcinog; 2017 Feb; 56(2):664-680. PubMed ID: 27377703
[TBL] [Abstract][Full Text] [Related]
38. CD40 engagement on dendritic cells induces cyclooxygenase-2 and EP2 receptor via p38 and ERK MAPKs.
Harizi H; Limem I; Gualde N
Immunol Cell Biol; 2011 Feb; 89(2):275-82. PubMed ID: 20697426
[TBL] [Abstract][Full Text] [Related]
39. EP4 and EP2 receptor subtypes involved in colonic secretion in rat.
Mosa AS; Hansen MB; Tilotta CM; Bindslev N
Basic Clin Pharmacol Toxicol; 2008 Sep; 103(3):214-21. PubMed ID: 18684231
[TBL] [Abstract][Full Text] [Related]
40. Receptors and signaling mechanisms required for prostaglandin E2-mediated regulation of mast cell degranulation and IL-6 production.
Nguyen M; Solle M; Audoly LP; Tilley SL; Stock JL; McNeish JD; Coffman TM; Dombrowicz D; Koller BH
J Immunol; 2002 Oct; 169(8):4586-93. PubMed ID: 12370397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
